| NCT Number | NCT07169864 |
| Lead Sponsor | Jinsong Lu |
| Conditions | Breast Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN), Neoadjuvant Therapy |
| Enrollment | 44 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2027-09-30 (estimated) |
| Study Completion | 2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-09-12 |